S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

Aralez Pharmaceuticals Inc. (ARZ.TO) Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume274,400 shs
Average Volume79,103 shs
Market CapitalizationC$28.89 million
P/E RatioN/A
Dividend YieldN/A
Aralez Pharmaceuticals Inc. operates as a specialty pharmaceutical company in the United States and Canada. It engages in acquiring, developing, and commercializing products in the areas of cardiovascular, pain management, dermatological allergy, and other indications. It offers Zontivity for the reduction of thrombotic cardiovascular events in patients with heart attack or peripheral arterial disease; Toprol-XL, a cardioselective beta-blocker that is indicated for the treatment of hypertension; Fibricor, a fenofibric acid for the treatment of severe hypertriglyceridemia and patients with primary hypercholesterolemia or mixed dyslipidemia; and Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial. The company also markets Cambia, a non-steroidal anti-inflammatory drug (NSAID) for the acute treatment of migraine attacks; Soriatane for the treatment of severe psoriasis and other disorders of keratinization; Proferrin, an iron supplement; Fiorinal and Fiorinal C for the relief of tension type headaches; and Bezalip SR, a pan-peroxisome proliferator-activated receptor activator to treat hyperlipidemia, as well as to increase insulin sensitivity and decrease blood glucose levels for the patients with metabolic syndrome. In addition, it provides out-licensed products, which include VIMOVO for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers; and Treximet, a migraine medicine. The company was incorporated in 2015 and is headquartered in Mississauga, Canada.
Aralez Pharmaceuticals Inc. (ARZ.TO) logo


Overall MarketRank

0.44 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Gold



Sales & Book Value

Annual SalesN/A



Market CapC$28.89 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive ARZ News and Ratings via Email

Sign-up to receive the latest news and ratings for ARZ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aralez Pharmaceuticals Inc. (ARZ.TO) (TSE:ARZ) Frequently Asked Questions

What stocks does MarketBeat like better than Aralez Pharmaceuticals Inc. (ARZ.TO)?

Wall Street analysts have given Aralez Pharmaceuticals Inc. (ARZ.TO) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aralez Pharmaceuticals Inc. (ARZ.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Aralez Pharmaceuticals Inc. (ARZ.TO)'s key competitors?

What other stocks do shareholders of Aralez Pharmaceuticals Inc. (ARZ.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aralez Pharmaceuticals Inc. (ARZ.TO) investors own include Aralez Pharmaceuticals (ARLZ), Westport Fuel Systems (WPRT), Advantage Oil & Gas (AAV), Athabasca Oil Co. (ATH.TO) (ATH), Yamana Gold (AUY), AVEO Pharmaceuticals (AVEO), Anavex Life Sciences (AVXL), Biopharmx (BPMX), Kintara Therapeutics (DMPI) and DRDGOLD (DRD).

Who are Aralez Pharmaceuticals Inc. (ARZ.TO)'s key executives?

Aralez Pharmaceuticals Inc. (ARZ.TO)'s management team includes the following people:
  • Mr. Adrian Adams, CEO & Director (Age 67)
  • Mr. Andrew I. Koven, Pres & Chief Bus. Officer (Age 60)
  • Mr. Michael Kaseta, Chief Financial Officer (Age 42)
  • Dr. James Patrick Tursi, Chief Medical Officer (Age 53)
  • Mr. John E. Barnhardt CPA, Principal Accounting Officer and VP of Fin. & Admin. (Age 68)

What is Aralez Pharmaceuticals Inc. (ARZ.TO)'s stock symbol?

Aralez Pharmaceuticals Inc. (ARZ.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ARZ."

How do I buy shares of Aralez Pharmaceuticals Inc. (ARZ.TO)?

Shares of ARZ and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

How big of a company is Aralez Pharmaceuticals Inc. (ARZ.TO)?

Aralez Pharmaceuticals Inc. (ARZ.TO) has a market capitalization of C$0.00.

What is Aralez Pharmaceuticals Inc. (ARZ.TO)'s official website?

The official website for Aralez Pharmaceuticals Inc. (ARZ.TO) is aralez.com.

How can I contact Aralez Pharmaceuticals Inc. (ARZ.TO)?

Aralez Pharmaceuticals Inc. (ARZ.TO)'s mailing address is 7100 West Credit Ave Suite 101, MISSISSAUGA, ON L5N 0E4, Canada. The company can be reached via phone at +1-905-8761118.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.